General Information

This course is now fully booked and closed for registrations. 

Pharmacogenomics is increasingly being recognised as a valuable way of reducing adverse drug reactions and improving drug effectiveness. This course aims to deliver up-to-date knowledge on how pharmacogenomics can be applied in clinical practice. The primary beneficiaries of the course will be drug prescribers with limited knowledge of pharmacogenomics. This course will be especially valuable for pharmacists, GPs and hospital physicians and nurse prescribers.

This in-person course facilitates opportunity for informal interaction and discussion with experts from across Europe. The faculty combines experts from genetics, pharmacology, pharmacy, laboratory science, all known for their teaching skills. As well as being of interest to individuals working in industry in diagnostics or therapeutics

For full information please read the ESHG Pharmacogenomics Course Manchester Programme 2026 to obtain a deeper understanding of the course content, sessions and expert trans-discipline faculty in attendance.

CPD accredited from the Royal College of Physicians (RCP) this in-person 3-day training course which will take place in the Renold Building @ SISTER in Manchester. We look forward to welcoming you.

This course is intended for:

• Pharmacists
• General Practitioners (GPs)
• Hospital Physicians
• Nurse Prescribers
• Healthcare professionals with limited pharmacogenomics knowledge
• Drug prescribers seeking to improve patient outcomes
• Industry professionals involved in diagnostics or therapeutics

Confirmed Speakers, learn from a transdisciplinary faculty of leading European experts:

• Prof Vita Dolžan — Professor and Head of Pharmacogenetics Laboratory, Faculty of Medicine, University of Ljubljana
• Dr Jude Hayward — GP with Special Interest in Clinical Genetics, Yorkshire Regional Genetics Service
• Dr Tore Haslemo — Clinical Pharmacologist and Researcher, Oslo University Hospital and University of Oslo
• Jessica Keen — Pharmacy Lead for Genomic Medicine, NHS North West Genomic Medicine Service Alliance
• Dr Emma Magavern — MRC Clinician Scientist and Lecturer in Clinical Pharmacology, Queen Mary University of London
• Prof Mikko Niemi — Professor of Pharmacogenetics, University of Helsinki
• Prof Katherine Payne — Professor of Health Economics, The University of Manchester
• Prof Sir Munir Pirmohamed — David Weatherall Chair in Medicine; NHS Chair of Pharmacogenetics; Consultant Physician, Royal Liverpool University Hospital
• Cristina Perez-Becerril — Clinical Scientist, North West Genomic Laboratory Hub
• Dr Cristina Rodríguez-Antona — Group Leader, Pharmacogenomics Programme, Spanish National Cancer Research Centre (CNIO)
• Dr Videha Sharma — Lecturer in Health Informatics, The University of Manchester
• Prof Jesse Swen — Associate Professor, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center
• Prof Ron van Schaik — Professor of Pharmacogenetics, Department of Clinical Chemistry, Erasmus University Medical Center

Programme

Click here to see the full programme